Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma

Vineeth Sukrithan, Jason Sandler, Rasim A. Gucalp, Richard J. Gralla, Balazs Halmos

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Tumor Burden
Immunotherapy
Carcinoma
Lung
pembrolizumab

Keywords

  • Checkpoint inhibitor
  • Immunotherapy
  • PD-L1
  • Pembrolizumab
  • Tumor mutational burden

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma. / Sukrithan, Vineeth; Sandler, Jason; Gucalp, Rasim A.; Gralla, Richard J.; Halmos, Balazs.

In: Clinical Lung Cancer, 01.01.2019.

Research output: Contribution to journalArticle

@article{915e3ce28b7a43febe7ee0e14f513e21,
title = "Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma",
keywords = "Checkpoint inhibitor, Immunotherapy, PD-L1, Pembrolizumab, Tumor mutational burden",
author = "Vineeth Sukrithan and Jason Sandler and Gucalp, {Rasim A.} and Gralla, {Richard J.} and Balazs Halmos",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cllc.2018.12.013",
language = "English (US)",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",

}

TY - JOUR

T1 - Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma

AU - Sukrithan, Vineeth

AU - Sandler, Jason

AU - Gucalp, Rasim A.

AU - Gralla, Richard J.

AU - Halmos, Balazs

PY - 2019/1/1

Y1 - 2019/1/1

KW - Checkpoint inhibitor

KW - Immunotherapy

KW - PD-L1

KW - Pembrolizumab

KW - Tumor mutational burden

UR - http://www.scopus.com/inward/record.url?scp=85060114496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060114496&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2018.12.013

DO - 10.1016/j.cllc.2018.12.013

M3 - Article

C2 - 30665873

AN - SCOPUS:85060114496

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

ER -